Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with alpha5-containing GABAA receptor agonists

Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with alpha5-containing GABAA receptor agonists

US Patent 12180216 · Granted Dec 31, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulators2024
Substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulators2024
Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2023
Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2023
Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2023
Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2023
Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2023
Substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulators2022
Substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulators2022
Ligands selective to alpha 6 subunit-containing GABAA receptors and their method2022
Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2021
Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2021